DUBLIN and BOSTON, Dec. 20, 2017 /PRNewswire/ — Allergan plc, (NYSE: AGN) a leading global pharmaceutical company, and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of…Original Article
FDA Accepts New Drug Application for Seysara (sarecycline) for the Treatment of Moderate to Severe Acne
